Literature DB >> 12639099

A novel defect in interferon-gamma secretion in patients with refractory nontuberculous pulmonary mycobacteriosis.

Amar Safdar, Donald Armstrong, Henry W Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12639099     DOI： 10.7326/0003-4819-138-6-200303180-00030

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Steven A Cowman; Joseph Jacob; David M Hansell; Peter Kelleher; Robert Wilson; William O C Cookson; Miriam F Moffatt; Michael R Loebinger
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

3.  IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.

Authors:  Xiyuan Bai; Alida R Ovrutsky; Marinka Kartalija; Kathryn Chmura; Amanda Kamali; Jennifer R Honda; Rebecca E Oberley-Deegan; Charles A Dinarello; James D Crapo; Ling-Yi Chang; Edward D Chan
Journal:  Int Immunol       Date:  2011-10-27       Impact factor: 4.823

4.  Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.

Authors:  Marinka Kartalija; Alida R Ovrutsky; Courtney L Bryan; Gregory B Pott; Giamila Fantuzzi; Jacob Thomas; Matthew J Strand; Xiyuan Bai; Preveen Ramamoorthy; Micol S Rothman; Vijaya Nagabhushanam; Michael McDermott; Adrah R Levin; Ashley Frazer-Abel; Patricia C Giclas; Judith Korner; Michael D Iseman; Leland Shapiro; Edward D Chan
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

5.  Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.

Authors:  A Safdar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-25       Impact factor: 3.267

6.  Changes in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Go Eun Yang; Yousang Ko; Yong Bum Park; Yun Su Sim; Sung Hoon Park; Chang Youl Lee; Ki-Suck Jung; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

7.  Non-tuberculous mycobacteria in patients with bronchiectasis.

Authors:  M Wickremasinghe; L J Ozerovitch; G Davies; T Wodehouse; M V Chadwick; S Abdallah; P Shah; R Wilson
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 8.  Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections.

Authors:  Mouhannad Sadek; Feng Yun Yue; Erika Yue Lee; Gabor Gyenes; R Brad Jones; Victor Hoffstein; David G Munoz; Ignatius Fong; Mario Ostrowski
Journal:  Clin Vaccine Immunol       Date:  2008-08-13

9.  Patients with Idiopathic Pulmonary Nontuberculous Mycobacterial Disease Have Normal Th1/Th2 Cytokine Responses but Diminished Th17 Cytokine and Enhanced Granulocyte-Macrophage Colony-Stimulating Factor Production.

Authors:  Un-In Wu; Kenneth N Olivier; Douglas B Kuhns; Danielle L Fink; Elizabeth P Sampaio; Adrian M Zelazny; Shamira J Shallom; Beatriz E Marciano; Michail S Lionakis; Steven M Holland
Journal:  Open Forum Infect Dis       Date:  2019-11-28       Impact factor: 3.835
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.